Psychotic (delusional) major depression: New vistas

Current Psychiatry Reviews

Volumn 5, Issue 1, 2009, Pages 1-28

  Lykouras, Lefteris ^a   Gournellis, Rossetos ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Delusional depression; Major depressive episode with psychotic features; Psychotic depression

Indexed keywords

AMITRIPTYLINE; AMOXAPINE; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CARBAMAZEPINE; CLOZAPINE; DESIPRAMINE; FLUOXETINE; FLUVOXAMINE; GLUCOCORTICOID ANTAGONIST; HALOPERIDOL; HYDROCORTISONE; IMIPRAMINE; LITHIUM; MIFEPRISTONE; MIRTAZAPINE; NEUROLEPTIC AGENT; NORTRIPTYLINE; OLANZAPINE; PAROXETINE; PERPHENAZINE; PINDOLOL; PLACEBO; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VENLAFAXINE;

ATTENTION DISTURBANCE; BIPOLAR DISORDER; BRAIN ATROPHY; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE DEFECT; DELUSION; DEPRESSIVE PSYCHOSIS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG MECHANISM; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTROCONVULSIVE THERAPY; ELECTROENCEPHALOGRAM; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; EXPERIMENTAL THERAPY; EXTRAPYRAMIDAL SYMPTOM; FAMILY HISTORY; GUILT; HALLUCINATION; HIGH RISK PATIENT; HUMAN; HYDROCORTISONE BLOOD LEVEL; INFORMATION RETRIEVAL; LIMBIC CORTEX; LONG TERM CARE; MAJOR DEPRESSION; MEDLINE; MEMORY DISORDER; METABOLIC SYNDROME X; MOOD DISORDER; NEUROBIOLOGY; NEUROCHEMISTRY; NEUROENDOCRINE SYSTEM; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PSYCHOMOTOR DISORDER; PSYCHOSIS; PSYCHOSURGERY; PSYCINFO; RECURRENT DISEASE; REVIEW; SUICIDAL BEHAVIOR; TARDIVE DYSKINESIA; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

EID: 65949124698     PISSN: 15734005     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340009787315271     Document Type: Review

References (202)

1. Coryell W, Leon A, Winokur G, et al. Importance of psychotic features to long-term course in major depressive disorder. Am J Psychiatry 1996; 153: 483-9.
2. Friedman AS, Granick S, Cohen HW, Cowitz B. Imipramine (Tofranil) vs. placebo in hospitalised psychotic depressives: a comparison of patients' self-ratings, psychiatrists' ratings and psychological test scores. J Psychiat Res 1966; 4: 13-36
3. Hordern A, Holt NF, Burt CG, Gordon WF. Amitriptyline in depressive states: Phenomenology and prognostic considerations. Br J Psychiatry 1963; 109: 815-25
4. Glassman AH, Perel JM, Shostak M, Kantor SJ, Fleiss JL. Clinical implications of imipramine plasma levels for depressive illness. Arch Gen Psychiatry 1977; 34: 197-204.
5. Kantor SJ, Glassman AH. Delusional depressions: natural history and response to treatment. Br J Psychiatry 1977; 131: 351-60.
6. Chan CH, Janicak PG, Davis JM, Altman E, Andriukaitis S, Hedeker D. Response of psychotic and nonpsychotic depressed patients to tricyclic antidepressants. J Clin Psychiatry 1987; 48: 197-200.
7. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. DSM IV. American Psychiatric Association. Fourth edition, Text Revision. Washington, DC, 2000; 345-428.
8. World Health Organization: The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. World Health Organization, Geneva, 1992
9. Keller J, Schatzberg A, Maj M. Current issues in the classification of psychotic major depression. Schizophren Bul 2007; 33: 877-85.
10. Swartz C, Shorter E. Psychotic depression. Cambridge University Press, New York, 2007.
11. Schatzberg AF, Rothschild AJ. Psychotic (delusional) major depression: should it be included as a distinct syndrome in DSM-IV? Am J Psychiatry 1992; 149: 733-45.
12. Meyers B. Geriatric depression. Clin Geriatr Med 1992; 8: 299-308.
13. Martinez R, Mulsant B, Meyers B, Lebowitz B. Delusional and Psychotic depression in late life. Am J Geriatr Psychiatry 1996; 4: 77-84.
14. Coryell W. Psychotic depression. J Clin Psychiatry 1996; 57[Supp 3]: 27-31.
15. Coryell W. The treatment of psychotic depression. J Clin Psychiatry 1998; 59 [Supp 1]: 22-7.
16. Baldwin RC. Delusional (psychotic) depression in the elderly. In: Marneros A Ed, Late-Onset Mental Disorders. Gaskell, London, 1999; 59-82.
17. Rothschild A. Challenges in the treatment of depression with psychotic features. Biol Psychiatry 2003; 53: 680-90.
18. Schatzberg AF. New approaches to managing psychotic depression. J Clin Psychiatry 2003; 64 [Supp 1]: 19-23.
19. Nelson C, Davis J. DST studies in psychotic depression: A meta-analysis. Am J Psychiatry 1997; 154:1497-503.
20. Flemming S, Blasey C, Schatzberg A. Neuropsychological correlates of psychotic features in major depressive disorders: a review and meta-analysis. J Psychiatr Res 2004; 38: 27-35.
21. Parker G, Kay R, Hadzi-Pavlovic D, Fadie P. Psychotic (delusional) depression: a meta-analysis of physical treatments. J Affect Disord 1992; 24: 17-24
22. Wijkstra J, Lijmer J, Balk F, Geddes J, Nolen WA. Pharmacological treatment for psychotic depression. Cochrane Database Syst Rev 2005, Issue 4. Art. No.: CD004044. DOI: 10.1002/14651858.-CD004044.pub2
23. Gournellis R, Lykouras L. Psychotic (delusional) major depression in the elderly: a review. Cur Psychiatr Rev 2006; 2: 235-44.
24. Johnson J, Horwath E, Weissman M. The validity of major depression with psychotic features based on a community study. Arch Gen Psychiatry 1991; 48: 1075-81.
25. Ohayon M, Schatzberg A: Prevalence of depressive episodes with psychotic features in the general population. Am J Psychiatry 2002;159: 1855-61.
26. Baldwin P, Browne D, Scully P, et al. Epidemiology of first-episode psychosis: illustrating the challenges across diagnostic boundaries through the Cavan-Monaghan study. Schizpophr Bull 2005; 31: 624-38.
27. Grebbin K, Mitford E, Paxton R, Turkington D. First-episode psychosis: an epidemiological survey comparing psychotic depression with schizophrenia. J Affect Disord 2008; 105:117-24.
28. Fennig S, Bromet E, Jandorf L. Gender differences in clinical characteristics of first-admission psychotic depression. Am J Psychiatry 1993; 150: 1734-6.
29. Thakur M, Hays J, Krishnan KR. Clinical, demographic and social characteristics of psychotic depression. Psychiatry Res 1999; 86: 99-106.
30. Kivela SL, Pahkala K. Delusional depression in the elderly: A community study. Z Gerontol 1989; 22: 236-41.
31. Baldwin RC. Delusional depression in elderly patients: Characteristics and relationship to age at onset. Int J Geriatr Psychiatry 1995; 10: 981-5.
32. Gournellis R, Lykouras L, Fortos A, Oulis P, Roumbos A, Chistodoulou GN. Psychotic (delusional) major depression in late life: a clinical study. Int J Geriatr Psychiatry 2001; 16:1085-91.
33. Kessing L. Differences in diagnostic subtypes among patients with late and early onset of a single depressive episode. Int J Geriatr Psychiatry 2006; 21: 1127-31.
34. Meyers BS, Greenberg R. Late-Life delusional depression. J Affect Disord 1986; 11:133-7.
35. Greenwald B, Kramer-Ginsberg E. Age at onset in geriatric depression: relationship to clinical variables. J Affect Disord 1988: 61-8.
36. Brodaty H, Peters K, Boyce P, et al. Age and depression. J Affect Disord 1991; 23: 137-49.
37. Brodaty H, Luscombe G, Parker G, et al. Increased rate of psychosis and psychomotor change in depression with age. Psychol Med 1997; 27: 1205-13.
38. Winokur G, Behar D. Schlesser M. Clinical and Biological Aspects of Depression in the Elderly. In: Cole O, Barrett J. Eds, Psychopathology in the Aged. Raven Press, New York, 1980;145-155.
39. Nelson J, Conwell Y, Kim K, Mazure C. Age at onset in late-life delusional depression. Am J Psychiatry 1989; 146:785-6.
40. Lattuada E, Serretti A, Cusin C, Gasperini M, Smeraldi E. Symptomatologic analysis of psychotic and non-psychotic depression. J Affect Disord 1999; 54: 183-7.
41. Benazzi F. Psychotic late-life depression: a 376-case study. Int Psychogeriatrics 1999; 11: 325-32
42. Lee TW, Tsai SJ, Yang CH, Hwang JP. Clinical and phenomenological comparisons of delusional and non-delusional major depression in the Chinese elderly. Int J Psychiatry 2003; 18: 486-90.
43. Parker G, Hadzi-Pavlovic D, Brodaty H, et al. Sub-typing depression: II. Clinical distinction of psychotic depression and non-psychotic melancholia. Psychol Med 1995; 25: 825-32.
44. Keller J, Gomez R, Kenna H, et al. Detecting psychotic major depression using psychiatric rating scales. J Psychiatr Res 2006; 22-9.
45. Parker G, Roussos J, Mitchell P, Wilhelm K, Austin M-P, Hadzi-Pavlovic D. Distinguishing psychotic depression from melancholia. J Affect Disord 1997; 42:155-67.
46. Parker G, Snowdon J, Parker K. Modelling late-life depression. Int J Geriatr Psychiatry 2003; 18: 1102-9.
47. Maj M, Pirozzi R, Magliano L, Fiorillo A, Bartolli L. Phenomenology and prognostic significance of delusions in major depressive disorder: a 10-year prospective follow-up study. J Clin Psychiatry 2007; 68: 1411-7.
48. Gaudiano B, Miller I. Dysfunctional cognitions in hospitalized patients with psychotic versus nonpsychotic major depression. Compr Psychiatry 2007; 48: 357-65.
49. Lenzi A, Rinaldi A, Bianco I, Balestri C, Marazziti D. Psychotic symptoms in mood disorders: evaluation of 159 inpatients. Eur Psychiatry 1996; 11:396-9.
50. Bellini L, Gatti F, Gasperini M, Smeraldi E. A comparison between delusional and non-delusional depressives. J Affect Disord 1992; 25: 129-38.
51. Serretti A, Lattuada E, Cusin C, Gasperini M, Smeraldi E. Clinical and demographic features of [psychotic and nonpsychotic depression. Compr Psychiatry 1999; 40: 358-62.
52. Parker G, Hadzi-Pavlovic D, Austin M-P, et al. Sub-typing depression, I. Is psychomotor disturbance necessary and sufficient to definition of melancholia? Psychol Med 1995; 25: 815-23.
53. Alexander GE, Delong R, Strick P. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Ann Rev Neurosci 1986; 9: 357-81.
54. Austin M-P, Michell P. Melancholia as a neurological disorder. In: Parker G, Hadzi-Pavlovic D Eds, Melancholia 1996; 223-6.
55. Parker G, Hickie I, Hadzi-Pavlovic D. Psychotic depression: clinical definition, status and the relevance of psychomotor disturbance to its definition. In: Parker G, Hadzi-Pavlovic D Eds, Melancholia 1996; 179-201.
56. Parker G. Classifying depression: should paradigms lost be regained? Am J Psychiatry 2000; 157: 1195-203.
57. Parker G, Roy K, Hadzi-Pavlovic D, et al. Subtyping depression by clinical features: the Australian database. Acta Psychiatr Scand 2000; 101: 21-8.
58. Benazzi F. Bipolar versus unipolar psychotic outpatient depression. J Affect Disorder 1999; 55: 63-66.
59. Dell' Osso L, Pini S, Cassano GB, et al. Insight into illness in patients with mania, mixed mania, bipolar depression and major depression with psychotic features. Bipolar Disord 2002; 4: 315-22.
60. Nelson C, Bowers M. Delusional unipolar depression: description and drug response. Arch Gen Psychiatry 1978; 35: 1321-8.
61. Charney DS, Nelson JC. Delusional and nondelusional unipolar depression: Further evidence for distinct subtypes. Am J Psychiatry 1981; 138: 328-33.
62. Frangos E, Athanassenas G, Tsitourides S, Psilolignos P, Katsanou N. Psychotic depressive disorder. A separate Entity? J Affect Disord 1983; 5: 259-65.
63. Lykouras E, Christodoulou GN, Malliaras D. Type and content of delusions in unipolar psychotic depression. J Affect Disord 1985; 9: 249-52.
64. Lykouras E, Malliaras D, Christodoulou GN, et al. Delusional depression: phenomenology and response to treatment. A prospective study. Acta Psychiatr Scand 1986; 73: 324-9.
65. Simpson S, Baldwin RC, Jackson A, Burns A. The differentiation of DSM-III-R psychotic depression in later life from nonpsychotic depression: Comparisons of brain changes measured by multispectral analysis of magnetic resonance brain images, neuropsychological findings and clinical features. Biol Psychiatry 1999; 45:193-204.
66. Gournellis R, Oulis P, Cristodoulou C, Kaparoudaki A, Fortos A, Lykouras L. Delusional beliefs in psychotic depression vary according to age of onset. Int J Geriatr Psychiatry 2008; 23: 1093-4.
67. Musalek M, Berner P, Katsching H. Delusional theme, sex and age. Psychopathology 1989; 22: 260-7.
68. Oulis P, Lykouras L, Gournellis R, Mamounas J, Hatzimanolis J, Christodoulou G.N. Clinical features of delusional beliefs in schizophrenic and unipolar mood disorders: a comparative study. Psychopathology 2000; 33: 310-13.
69. Meyers B, English J, Gabriele M, et al. A delusion assessment scale for psychotic major depression: reliability, validity and utility. Biol Psychiatry 2006; 60: 1336-42.
70. Gournellis R, Oulis P, Michalopoulou P, Kaparoudaki A, Dimitrakopoulos C, Lykouras L. Dimensional approach to delusions in psychotic depression in the elderly: factor structure and clinical correlates. In Press. DOI: 10.1002/gps.2130.
71. Kendler S. Mood-incongruent psychotic affective illness. Arch Gen Psychiatry 1991; 48: 362-9.
72. Burch E, Anton R, Carson W. Mood congruent and incongruent psychotic depressions: are they the same? J Affect Disord 1994; 31: 275-80.
73. Fenning S, Bromet E, Tanenberg-Karant M, Ram R, Jandorf L. Mood-congruent versus mood-incongruent psychotic symptoms in first-admission patients with affective disorder. J Affect Disord 1996; 23-9.
74. Naz B, Craig T, Bromet E, Finch S, Fochtmann L, Carson G. Remission and relapse after the first hospital admission in psychotic depression: a 4-year naturalistic follow-up. Psychol Med 2007; 37: 1173-81.
75. Tsuang D, Coryell W. An 8-year follow-up of patients with DSM-III-R psychotic depression, schizoaffective disorder, and schizophrenia. Am J Psychiatry 1993; 150: 1182-8.
76. Anton R, Burch E. Response of psychotic depression subtypes to pharmacotherapy. J Affect Disord 1993; 28: 125-31.
77. Goes F, Zandi P, Miao K, et al. Mood-incongruent psychotic features in bipolar disorder: familial aggregation and suggestive linkage to 2p11-q14 and 13q21-33. Am J Psychiatry 2007; 164: 236-47.
78. Baethge C, Baldessarini R, Freudenthal K, Streeruwitz A, Bauer M, Bschor T. Hallucinations in bipolar disorder: characteristics and comparison to unipolar depression and schizophrenia. Bipolar Disord 2005; 7: 136-45.
79. Harrow M, Grossman L, Herbener E, Davies E. Ten-year outcome: patients with schizoaffective disorders, schizophrenia, affective disorders and mood-incongruent psychotic symptoms. Br J Psychiatry 2000; 177: 421-6.
80. Jäger M, Bottlender R, Strauss A, Möller H-J. Fifteen-year follow-up of Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition depressive disorders: the prognostic significance of psychotic features. Compr Psychiatry 2005; 46: 322-7.
81. Leyton M, Corin E, Martial J, Meaney M. Psychotic symptoms and vulnerability to recurrent major depression. J Affect Disord 1995; 33: 107-15.
82. Flint A, Rifat S. Two-year outcome of psychotic depression in late life. Am J Psychiatry 1998; 155: 178-83.
83. Goes FS, Salder G, Toolan J, et al. Psychotic features in bipolar and unipolar depression. Bipolar Disord 2007; 9: 901-6.
84. Vythilingam M, Chen J, Bremner JD, Mazure C, Maciejewski P, Nelson JC. Psychotic depression and mortality. Am J Psychiatry 2003; 160: 574-6.
85. Lykouras L, Christodoulou C, Malliaras D, Stefanis C. The prognostic importance in depression: a 6-year prospective follow-up study. J Affect Disord 1994; 32: 233-8.
86. Naz B, Craig T, Bromet E, Finch S, Fochtmann L, Carlson G. Remission and relapse after the first hospital admission in psychotic depression: a 4-year naturalistic follow-up. Psychol Med 2007; 37: 1173-81.
87. Wilcox JA, Ramirez A, Baida-Fragoso N. The prognostic value of thought disorder in psychotic depression. Ann Clin Psychiatry 2000; 12: 1-4.
88. Fennig S, Bromet E, Tanenberg Karant M, Ram R, Jandorf L. Mood-congruent versus mood-incongruent psychotic symptoms in first-admission patients with affective disorder. J Affect Disord 1996; 37: 23-9.
89. Mitchell PB, Wilhelm K, Parker G, Austin MP, Rutgers P, Malhi GS. The clinical features of bipolar depression: a comparison with matched major depressive disorder patients. J Clin Psychiatry 2001; 62: 212-6.
90. Rybakowski JK, Suwalska A, Lojko D, Rymaszewska J, Kiejna A. Bipolar mood disorders among Polish psychiatric outpatients treated for major depression. J Affect Disord 2005; 84: 141-7.
91. Akiskal H, Maser J, Zeller P, et al. Switching from "Unipolar" to Bipolar II. Arch Gen Psychiatry 1995; 52: 114-23.
92. Goldberg J, Harrow M, Whiteside J. Risk for bipolar illness in patients initially hospitalized for unipolar depression. Am J Psychiatry 2001; 158: 1265-70.
93. Coryell W, Winokur G, Shea T, Maser J, Endicott J, Akiskal H. The long-term stability of depressive subtypes. Am J Psychiatry 1994; 151: 199-204.
94. Roose SP, Glassman AH, Walsh BT, Woodring S, Vital-Herne J. Depression, delusions, and suicide. Am J Psychiatry 1983; 140: 1159-62.
95. Westermeyer J, Harrow M, Marengo J. Risk for suicide in schizophrenia and other psychotic and nonpsychotic disorders. J Nerv Ment Dis 1991; 179: 259-66.
96. Robinson DE, Spiker DG. Delusional depression. One year follow-up. J Affect Disord 1985, 9:79-83.
97. Wolfersdorf M, Keller F, Steiner B, Hole G. Delusional depression and suicide. Acta Psychiatr Scand 1987; 76: 359-63.
98. Fawcett J, Scheftner W, Clark D, Hedeker D, Gibbons B, Coryell W. Clinical predictors of suicide in patients with major affective disorders: A controlled prospective study. Am J Psychiatry 1987; 144: 35-40
99. Hori M, Shiraishi H, Koizumi J. Delusional depression and Suicide. Jpn J Psychiatry Neurol 1993; 47:811-7.
100. Isometsä E, Henriksson M, Aro H, Heikkinen M, Kuoppasalmi K, Lönnqvist J. Suicide in psychotic major depression. J Affect Disord 1994; 31: 187-91.
101. Lykouras L, Gournellis R, Fortos A, Oulis P, Christodoulou GN, Psychotic (delusional) major depression in the elderly and suicidal behaviour. J Affect Disord 2002; 69:225-9.
102. Lyness JM, Conwell Y, Nelson JC. Suicide attempts in elderly psychiatric inpatients. J Am Geriatr Soc 1992; 40: 320-4.
103. Malone KM, Haas GL, Sweeney JA, Mann JJ. Major depression and the risk of attempted suicide. J Affect Disord 1995; 34: 173-85.
104. Rothschild A, Benes F, Hebben N, et al. Relationships between brain CT span findings and cortizol in psychotic and nonpsychotic depressed patients. Biol Psychiatry 1989; 26: 565-75.
105. Jeste DV, Heaton SC, Paulsen JS, Ercoli L, Harris J, Heaton R. Clinical and neuropsychological comparison of psychotic depression with monpsychotic depression and schizophrenia. Am J Psychiatry 1996; 153: 490-6.
106. Nelson E, Sax K, Strakowski S. Attentional performance in patients with psychotic and nonpsychotic major depression and schizophrenia. Am J Psychiatry 1998; 155: 137-9.
107. Basso M, Boenstein R. Neuropsychological deficits in psychotic versus nonpsychotic unipolar depression. Neuropsychology 1999; 13: 69-75.
108. Schatzerg A. Neuropsychological deficits in psychotic versus nonpsychotic major depression and no mental illness. Am J Psychiatry 2000: 157:1095-100.
109. Politis A, Lykouras L, Mourtzouchou P, Christodoulou GN. Attentional disturbances in patients with unipolar psychotic depression: a selective and sustained attention study. Compr Psychiatry 2004; 45:452-9.
110. Gomez R, Fleming S, Keller J, et al. The neuropsychological profile of psychotic major depression and its relation to cortizol. Biol Psychiatry 2006; 60: 472-8.
111. Kunik M, Champagen L, Harper R, Chacko C. Cognitive functioning in elderly depressed patients with and without psychoses. Int J Gen Psychiatry 1994; 9: 871-4.
112. Kim DK, Kim BL, Sohn SE, et al. Candidate neuroanatomic substrates of psychosis in old-aged Depression. Prog Neuropsychopharmacol Biol Psychiatry 1999; 123: 793-807.
113. Ilonen T, Taiminen T, Karlsson H, et al. Impaired Wisconsin Card Sorting Test performance in first-episode severe depression. Nord J Psychiatry 2000; 54: 275-9.
114. Belanoff J, Kalehzan M, Sund B, Fleming Ficek S, Schatzberg A. Cortizol activity and cognitive changes in psychotic depression. Am J Psychiatry 2001; 158: 1612-16.
115. Hill SK, Keshavan M, Thase M, Sweeney J. Neuropsychological dysfunction in antipsychotic-naïve first-episode unipolar psychotic depression. Am J Psychiatry 2004: 161: 996-1003.
116. Seretti A, Macciardi F, Cusin C, Lattuada E, Lilli R, Smeraldi E. Dopamine receptor D4 gene is associated with delusional symptomatology in mood disorders. Psychiatry Res 1998; 80: 129-36.
117. Wood JG, Joyce PR, Miller AL, Mulder RT, Kennedy MA. A polymorphism in the dopamine beta-hydroxylase gene is associated with "paranoid ideation" in patients with major depression. Biol Psychiatry 2002; 51:365-9.
118. Iga J-I, Uemo S-I, Yamauchi K, et al. The Val66Met polymorphism of the Brain-Derived Neurotrophic Factor gene is associated with psychotic feature and suicidal behavior in Japanese major depressive patients. Am J Med Genetic Part B 2007; 144B: 1003-6.
119. Perez J, Tardito D, Racagni G, Smeraldi E, Zanardi R. c AMP signaling pathway in depressed patients with psychotic features. Mol Psychiatry 2002; 7: 208-12.
120. Seretti A, Benedetti F, Mandelli L, et al. Association between GSK-3β-50T/C polymorphism and personality and psychotic symptoms in mood disorders. Psychiatr Res 2008; 158: 132-40.
121. Zubenko G, Henderson R, Stiffer S, Stabler S, Rosen J, Kaplan B. Association of the APOE e4 allele with clinical subtypes of late life depression. Biol Psychiatry 1996; 40: 1008-16.
122. Meyers BS, Alexopoulos GS, Kakuma T, et al. Decreased dopamine beta-hydroxylase activity in unipolar geriatric delusional depression. Biol Psychiatry 1999; 45: 448-52.
123. Cubells JF, Price LH, Meyers BS, et al. Genotype-controlled analysis of plasma dopamine beta-hydroxylase activity in psychotic unipolar depression. Biol Psychiatry 2002; 51: 358-64.
124. Lykouras L, Markianos M, Malliaras D, Stefanis C. Neurochemical variables in delusional depression. Am J Psychiatry 1988; 145: 214-7.
125. Schatzberg A, Posener J, Rothschild A. The role of dopamine in psychotic depression. Clin Neuropharmacol 1995; 18: S66-S73.
126. Posener JA, DeBattista C, Williams GH, Kraemer HC, Kalehzan BM, Schatzberg AF. 24-hour monitoring of cortizol and corticotrophin secrection in psychotic and nonpsychotic major depression. Arch Gen Psychiatry 2000; 57: 755-60.
127. Keller J, Flores B, Gomez R, et al Cortizol circardian rhythm alterations in psychotic major depression. Biol Psychiatry 2006; 60: 275-81.
128. Owashi T, Otsubo T, Oshima A, Nakagone K, Higuchi T, Kamijima K. Longitudinal neuroendocrine changes assessed by dexamethasone/CRH and growth hormone releasing hormone tests in psychotic depression. Psychoendocrinology 2008; 33: 152-61
129. Contreras F, Navarro M, Menchon J, et al. Growth hormone response to growth hormone releasing hormone in non-delusional and delusional depression and healthy controls. Psychol Med 1996; 26: 301-7.
130. Duval F, Mokrani MC, Crocq MA, et al. Dopamine function and the cortizol response to dexamethazone in psychotic depression. Prog Neuro-Psychopharmacol Biol Psychiat 2000; 24: 204-25
131. Lykouras L, Markianos M, Hatzimanolis J, Oulis P, Christodoulou G. Prolactin secretion in response to haloperidol challenge in delusional (psychotic) and non-delusional depression. Eur Psychiatry 2000; 15: 480-2.
132. Lykouras L, Markianos M, Hatzimanolis J, Malliaras D, Stefanis C. Biogenic amine metabolites in delusional (psychotic) depression and melancholia subtypes of major depression. Prog Neuro-Psychopharmacol Biol Psychiat 1994; 18: 1261-71.
133. Lykouras L, Markianos M, Hatzimanolis J, Malliaras D, Stefanis C. Association of biogenic amine metabolites with symptomatology in delusional (psychotic) and nondelusional depressed patients. Prog Neuro-Psychopharmacol Biol Psychiat 1995; 19: 877-87.
134. Lee B-H, Kim H, Park S-H, Kim Y-K. Decreased plasma BDNF level in depressive patients. J Affect Disord 2007; 101:239-44.
135. Rizos E, Rontos I, Laskos E, Arsenis G, Michalopoulou P, Vasilopoulos D, Gournellis R, Lykouras L. Investigation of serum BDNF levels in drug-naive patients with schizophrenia. Prog Neuro-Psychopharmacol Biol Psychiat. In Press.
136. 3H] imipramine binding in delusional compared with non-delusional endogenously depressed patients. J Affect Disord 2002; 72: 95-101.
137. Salokangas R, Cannon T, Van Erp T, et al. Structural magnetic resonance imaging in patients with first-episode schizophrenia, psychotic and severe non-psychotic depression and healthy controls. Br J Psychiatry 2002; 181[supp 43]: s58-s65.
138. Skaf C, Yamada A, Garrido G, et al. Psychotic symptoms in major depressive disorder are associated with reduced regional cerebral blood flow in the subgenual anterior cingulate cortex: a voxel-based single photon emission computed tomography (SPECT) study. J Affect Disord 2002; 68: 295-305.
139. Gonul A, Kula M, Bilgin A, Tutus A, Oguz A. The regional cerebral blood flow changes in major depressive disorder with and without psychotic features. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28: 1015-21.
140. O'Brien JT, Ames D, Schweitzer I, Desmond P, Coleman P, Tress B. Clinical, magnetic resonance imaging and endocrinological differences between delusional and non-delusional depression in the elderly. Int J Geriatr Psychiatry 1997; 12: 211-8.
141. Sommer I, Veer A, Wijkstra J, Boks M, Kahn R. Comparing language lateralization in psychotic mania and psychotic depression to schizophrenia; a functional MRI study. Schizophrenia Res 2007; 89: 364-5.
142. Crow TJ, Ball DJ, Bloom A. Schizophrenia as an anomaly of development of cerebral asymmetry. Arch Gen Psychiatry 1989; 46:1145-50.
143. Stefos G, Staner L, Van Veeren C, et al. Sleep EEG in psychotic and non psychotic depressive patients matched for age, gender and polarity. Acta Psychiatr Belg 1994; 94: 108-9.
144. Stefos G, Staner L, Kerkhofs M, Hubain P, Memdlewicz J, Linkowski P. Shorted REM latency as a psychobiological marker for psychotic depression? An age-, gender-, and polarity-controlled study. Biol Psychiatry 1998; 44: 1314-20.
145. Santosh P, Malhorta S, Raghunathan M, Mehra Y. A study of P300 in melancholic depression - correlation with psychotic features. Biol Psychiatry 1994; 35: 474-9.
146. Karaaslan F, Gonul A, Oguz A, Erdogan E, Esel E. P300 changes in major depressive disorders with and without psychotic features. J Affect Disord 2003; 73: 283-7.
147. Moeller O, Evers S, Deckert J, et al. The impact of ziprasidone in combination with sertraline on visually-evoked event-related potentials in depressed patients with psychotic features. Prog Neuro-Psychopharmacol Biol Psychiat 2007; 31:1440-3.
148. Papageorgiou C, Alevisos V, Ventouras E, Kontopantellis E, Uzunoglu N, Christodoulou C. Psychophysiological correlates of patients with delusional misidentification syndromes and psychotic major depression. J Affect Disord 2004; 81: 147-52.
149. Lykouras L, Vassilopoulos D, Voulgari A, Stefanis C, Malliaras D. Delusional depression: further evidence of genetic contribution. Psychiatry Res 1987; 21: 277-83.
150. Goldstein R, Horwath E, Wickramarate P, Wolk S, Warner V, Weissman M. Familial aggregation of delusional depression: re-examination in a recent family study. Depress Anxiety 1998; 8: 160-5.
151. Lambourn J, Gill D. A controlled comparison of simulated and real ECT. Br J Psychiatry 1978; 133: 514-9.
152. Brandon S, Cowley P, Mc Donald C et al. Electroconvulsive therapy: results in depressive illness from the Leistershire trial. Br Med J 1984; 288: 22-5.
153. Clinical Research Center. The Norwick Park ECT trial: predictors of response to real and simulated ECT. Br J Psychiatry 1984; 144: 227-37.
154. Friedman AS, Granick S, Cohen HW, Cowitz B. Imipramine (Tofranil) vs. placebo in hospitalised psychotic depressives: a comparison of patients' self-ratings, psychiatrists' ratings and psychological test scores. J Psychiat Res 1966; 4: 13-36.
155. Brown R, Frances A, Kocsis JH, Mann J. Psychotic vs. nonpsychotic depression: comparison of treatment response. J Nerv Ment Dis 1982; 170: 635-7
156. Wijkstra J, Lijmer J, Balk F, Geddes JR, Nolen WA. Pharmacological treatment for unipolar psychotic depression. Br J Psychiatry 2006; 188: 410-5
157. van den Broek WW, Birkenhäger TK, Mulder PG, Bruijn J, Moleman P. A double blind study comparing imipramine with fluvoxarnine in depressed inpatients. Psychopharmacology 2004; 175: 481-6.
158. Bruijn JA, Moleman P, Mulder PG, et al. A double-blind, fixed blood-level study comparing mirtazapine with imipramine in depressed in-patients. Psychopharmacology 1996; 127: 231-7.
159. Zanardi R, Franchini L, Gasperini M, Perez J, Smeraldi E. Double-blind controlled trial of sertraline versus paroxetine in the treatment of delusional depression. Am J Psychiatry 1996; 153: 1631-3.
160. Zanardi R, Franchini L, Serretti A, Perez J, Smeraldi E. Venlafaxine versus fIuvoxamine in the treatment of delusional depression: a pilot double-blind controlled study. J Clin Psychiatry 2000; 61: 26-9.
161. Rothschild AJ, Williamson DJ, Tohen MF, et al. A double-blind. randomized study of olanzapine and olanzapine/fluoxetine combination for major depression with psychotic features. J Clin Psychopharmacol 2004; 24: 365-73.
162. Minter RE, Mandel MR. The treatment of psychotic major depressive disorder with drugs and electroconvulsive therapy. J Nerv Ment Dis 1979; 167: 726-33.
163. Spiker DG, Weiss J, Dealy R, et al. The pharmacological treatment of delusional depression. Am J Psychiatry 1985; 142: 430-6.
164. Wijkstra J, Burger H, van den Broek W, et al. Pharmacological treatment of psychotic depression, a randomized, double-blind study comparing imipramine, venlafaxine and venlafaxine plus quetiapine. Presented at the 161st annual meeting of the American Psychiatric Association; May 3-8, 2008; Washington.
165. Dubovsky SL. Challenges in a conceptualizing psychotic mood disorders. Bull Menninger Clin 1994; 58: 198-214.
166. Nelson EB, McElroy SL. Psychotic depression. A guide to drug choice. CNS Drugs 1997; 8: 453-73.
167. Spiker DG, Perel JM, Hanin J, et al. The pharmacological treatment of delusional depression. Part II. J Clin Psychopharmacol 1986; 6: 339-42
168. Brandon S, Cowley P, McDonald C, Neville P, Palmer R, Wellstood-Eason S. Electroconvulsive therapy: results in depressive illness from the Leicestershire trial. Br Med J 1984; 288: 22-5.
169. Pande A, Krugler T, Haskett R, et al. Predictors of response to electroconvulsive therapy in delusional and nondelusional depressive disorder. J Affect Dirord 1990; 19: 215-9.
170. Wheeler Vega JA, Mortimer AM, Tyson PJ. Somatic treatment of psychotic depression: Review and recommendations for practice. J Clin Psychopharmacol 2000; 20: 504-19
171. Müller-Siecheneder F, Muller MJ, Hillert A, et al. Risperidone versus haloperidol and amitriptyline in the treatment of patients with a combined psychotic and depressive syndrome. J Clin Psychopharmacol 1998; 18: 111-20.
172. Kroessler D. Relative efficacy rates for therapies of delusional depression. Convuls Ther 1985; 1:173-82.
173. Rothschild AJ, Samson JA, Bessette MP, et al. Efficacy of the combination of fluoxetine and perphenazine in the treatment of psychotic depression. J Clin Psychiatry 1993; 54: 338-42.
174. Amore M, Giordani L, Giorgetti G, et al. Pharmacological treatment of delusional depression. Minerva Psichiatr 1996; 37: 29-33.
175. Ebert D. Lithium-TCA combination treatment of psychotic depression: comparison with TCA-neuroleptic treatment. J Clin Psychopharmacol 1997; 17: 129-30.
176. Mulsant BH, Sweet RA, Rosen J, et al. A double-blind randomized comparison of nortripryline plus perphenazine versus nortripryline plus placebo in the treatment of psychotic depression in late life. J Clin Psychiatry 2001; 62: 597-604.
177. Sacheim HA, Prudic J, Devanand DP, et al. The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression. J Clin Psychopharmacol 1990; 10: 96-104.
178. Sackeim HA, Haskett RF, Mulsant BH, et al. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. JAMA 2001; 285: 1299-307.
179. Andreescu C, Mulsant BH, Rothcshild AJ, Flint AJ, Meyers BS, Whyte E. Pharmacotherapy of major depression what is the evidence? Psychiatr Ann 2006; 36: 31-4.
180. Bellini L, Gasperini M, Gatti F, Franchini L, Smeraldi E. A double blind study with fluvoxamine vs. desipramine combined with placebo or haloperidol in delusional depression. Critical issues in the treatment of affective disorders 1994; 9: 32-6.
181. Zanardi R, Franchini L, Gasperini M, Lucca A, Smeraldi E, Perez J. Faster onset of action of fluvoxamine in combination with pindolol in the treatment of delusional depression: a controlled study. J Clin Psychopharmatmacol 1998; 18: 441-6.
182. Simpson GM, El Sheshai A, Rady A, Kingsbury SJ, Fayek M. Sertraline as monotherapy in the treatment of psychotic depression. J Clin Psychiatry 2003; 64: 959-65.
183. Wijkstra J, Schubort CD, Nolen WA. Treatment of unipolar psychotic depression: The use of evidence in practice guidelines. The World J Biol Psychiatry 2007; 1-7.
184. Rothschild AJ, Phillips KA, Selective serotonin reuptake inhibitors and delusional depression. Am J Psycchiatry 1999; 156: 977-78.
185. Kantrowitz JT, Tampi RR. Risk of psychosis exacerbation by tricyclic antidepressant in unipolar major depressive disorder with psychotic features. J Affect Disord 2008; 106: 278-84.
186. Birkenhäger TK, van den Broek WW, Mulder PG, Moleman P, Bruijn JA. Efficacy of imipramine in psychotic versus nonpsychotic depression. J Clin Psychopharmacol 2008; 28: 166-70.
187. Schatzberg AF, Lindley S. Glucocorticoid antagonists in neuropsychiatric disorders. Eur J Pharmacol 2008; 583: 358-64.
188. Schatzberg AF, Rothschild AJ, Langlais PJ, Bird ED, Cole JO. A corticosteroid-dopamine hypothesis for psychotic depression and related states. J Psychiat Res 1985; 19: 57-64
189. Gaillard RC, Riondel A, Muller AF, Herrmann W, Baulieu EE. RU 486: A steroid with antiglucocorticosteroid activity that only disinhibits the human pituitary-adrenal system at a specific time of day. Med Sci 1984; 81: 3879-82
190. Betragna X, Escourolle H, Pinquier JL, et al. Administration of RU486 for 8 Days in normal volunteers: Antiglucocorticoid effect with no evidence of peripheral cortisol deprivation. J Clin Endocrinol Metab 1994; 78: 375-80
191. Flores BH, Kenna H, Kellar J, Solvason HB, Schatzberg AF. Clinical and biological effects of mifepristone treatment for psychotic depression. Neuropsychopharmacology 2006; 31: 628-36.
192. Debatista C, Belanoff J, Glass S, et al. Cortisol hypersecretion in unipolar major depression with melancholic and psychotic features: dopaminergic noradrenergic and thyroid variables. Psychoneuroendocrinology 2006; 31: 875-88.
193. Caroll BJ, Rubin RT. Is mifepristone useful in psychotic depression? Neuropsychopharmacology 2006; 31: 2793-4.
194. Corcept Therapeutics: Corcept therapeutics announces negative results from the first of the three phase 3 studies evaluating COR-LUX (R) for treating the psychotic features of psychotic major depression. Available at: http://biz.Yahoo.com/prnews/060825/laf-018.html?.v=61. Accessed August 25, 2006.
195. Corcept Therapeuties: Corcept therapeutics announces negative results from the second of the three phase 3 studies evaluating CORLUX (R) for treating the psychotic features of psychotic major depression. Available at: http://biz.Yahoo.com//prnews/060929/sff012.html?v=76. Accessed Semtember 29, 2006.
196. Caroll BJ, Rubin RT. Mifepristone in psychotic depression. Biol Psychiatry 2008; 63: e1
197. Blasey C, Debatista C. Mifepristone in psychotic depression. Reply Biol Psychiatry 2008; 63: e3
198. Rothschild AJ, Duval SE. How long should patients with psychotic depression stay on the antipsychotic medication? J Clin Psychiatry 2003; 64: 390-6
199. Meyers BS, Klimstra SA, Gabriele M, et al. Continuation treatment of delusional depression in older adults. Am J Geriatr Psychiatry 2001; 9: 415-22.
200. Alexopoulos G, Katz I, Reynolds C, Carpenter D, Docherty J. Pharmacotherapy of depressive disorders in older patients. Postgrad Med 2001; A Special Report.
201. Baptista T, De Mentosa S, Beaulieu S, Bermudez A, Martinez M. The metabolic syndrome during atypical antipsychotic drug treatment: mechanisms and management. Metab Syndr Relat Disord 2004; 2: 290-307.
202. Smith E, Rothschild A, Heo M, et al. Meyers B and for the Study of the pharmacotherapy of Psychotic Depression (Stop-PD), Collaborative Study Group. Int Clin Psychopharmacol 2008; 23: 130-7.